Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Triple-Negative Breast Cancer

Research To Practice | Oncology Videos

Featuring perspectives from Drs P Kelly Marcom, Joyce O’Shaughnessy and Hope S Rugo and Professor Peter Schmid, including the following topics:

• Introduction (0:00)
• Optimal Integration of Immune Checkpoint Inhibitors into the Management of Metastatic Triple-Negative Breast Cancer (mTNBC) — Professor Peter Schmid, MD, PhD (2:00)
• Novel Applications of Immune Checkpoint Inhibitors for Patients with Early TNBC — Hope S Rugo, MD (34:59)
• Current and Future Role of PARP Inhibitors for Patients with TNBC and a BRCA Mutation — P Kelly Marcom, MD (45:40)
• Current and Future Management of PD-L1-Negative mTNBC — Joyce O’Shaughnessy, MD (1:11:19)

CME information and select publications